ArticleTransplantation2022

Poor Serologic Response to 2 Doses of an mRNA-based SARS-CoV-2 Vaccine in Lung Transplant Recipients.

Thijs W Hoffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.